Emmet B. Keeffe
#134,078
Most Influential Person Now
Emmet B. Keeffe's AcademicInfluence.com Rankings
Emmet B. Keeffephilosophy Degrees
Philosophy
#6673
World Rank
#9748
Historical Rank
Logic
#3806
World Rank
#5017
Historical Rank

Download Badge
Philosophy
Emmet B. Keeffe's Degrees
- Doctorate Medicine Harvard University
Why Is Emmet B. Keeffe Influential?
(Suggest an Edit or Addition)Emmet B. Keeffe's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2008 update. (2008) (562)
- A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. (2006) (428)
- A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. (2004) (424)
- Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. (2001) (324)
- Hepatitis B virus genotypes in the United States: results of a nationwide study. (2003) (316)
- Validation of a recording spectrophotometric method for measurement of membrane-associated Mg- and NaK-ATPase activity. (1979) (313)
- Report of an international workshop: Roadmap for management of patients receiving oral therapy for chronic hepatitis B. (2007) (276)
- Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? (1995) (262)
- Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease (1998) (261)
- Management of Antiviral Resistance in Patients with Chronic Hepatitis B (2004) (253)
- Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis. (1998) (245)
- Liver transplantation: current status and novel approaches to liver replacement. (2001) (225)
- Prevalence of HBV precore/core promoter variants in the United States (2003) (225)
- Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation. (2005) (210)
- Prevalence and treatment of hepatitis C virus genotypes 4, 5, and 6. (2005) (208)
- Health-related quality of life after liver transplantation: a meta-analysis. (1999) (205)
- 1989 A/S/G/E survey of endoscopic sedation and monitoring practices. (1990) (192)
- Development and evaluation of the liver disease quality of life instrument in persons with advanced, chronic liver disease—the LDQOL 1.0 (2000) (183)
- Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. (1997) (181)
- Racial differences in effectiveness of α‐fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis (2002) (173)
- Re‐treatment of chronic hepatitis C with consensus interferon (1998) (172)
- Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. (1999) (171)
- Cost‐effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C (2004) (164)
- Improved virologic response in chronic hepatitis C genotype 4 treated with nitazoxanide, peginterferon, and ribavirin. (2009) (147)
- Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients (1996) (140)
- Liver transplantation for patients with alcoholism and end-stage liver disease. (1993) (135)
- Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation (2009) (131)
- Viral Hepatitis and Other Infectious Diseases in a Homeless Population (2002) (128)
- Tuberculosis in liver transplant recipients: A systematic review and meta‐analysis of individual patient data (2009) (124)
- Systematic review: lamivudine prophylaxis for chemotherapy‐induced reactivation of chronic hepatitis B virus infection (2006) (124)
- Review article: current antiviral therapy of chronic hepatitis B (2011) (124)
- Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes. (2003) (118)
- Transjugular liver biopsy (1992) (117)
- Management of biliary complications after liver transplantation. (1992) (116)
- An explicit quality indicator set for measurement of quality of care in patients with cirrhosis. (2010) (114)
- Outcome of liver transplantation in patients with hemochromatosis (1994) (112)
- Liver transplantation for alcoholic liver disease: Current concepts and length of sobriety (2004) (112)
- Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection (2005) (109)
- General management. (2005) (106)
- Fibrosing cytolytic liver failure secondary to recurrent hepatitis B after liver transplantation. (1992) (104)
- Survival after liver transplantation in patients with hepatic iron overload: the national hemochromatosis transplant registry. (2005) (100)
- Lamivudine therapy for chemotherapy-induced reactivation of hepatitis B virus infection (1999) (98)
- Neurological complications of liver transplantation in adult versus pediatric patients. (1994) (96)
- Older age and liver transplantation: A review (2004) (95)
- Hepatitis vaccination in patients with chronic liver disease (2004) (94)
- Impact of Virologic Breakthrough and HBIG Regimen on Hepatitis B Recurrence After Liver Transplantation (2010) (94)
- Therapy of hepatitis C: Consensus interferon trials (1997) (94)
- Primary liver cancer and survival in patients undergoing liver transplantation for hemochromatosis. (1995) (93)
- Gastrointestinal symptoms of marathon runners. (1984) (92)
- Employment and alcohol use after liver transplantation for alcoholic and nonalcoholic liver disease: A systematic review (2001) (90)
- Alteration of rat liver plasma membrane fluidity and ATPase activity by chlorpromazine hydrochloride and its metabolites. (1980) (89)
- Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. (2005) (88)
- Current indications and contraindications for liver transplantation. (2007) (87)
- Allograft rejection after liver transplantation for autoimmune liver diseases. (1998) (86)
- Elevated AST or ALT to nonalcoholic fatty liver disease: accurate predictor of disease prevalence? (2003) (85)
- Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. (2001) (85)
- Detection and treatment of coronary artery disease in liver transplant candidates (2001) (84)
- Are infectious agents involved in primary biliary cirrhosis? A PCR approach. (1999) (83)
- Clinical course of hepatitis B virus infection during pregnancy (2009) (82)
- Keratin 8 and 18 mutations are risk factors for developing liver disease of multiple etiologies (2003) (79)
- Nonalcoholic fatty liver disease. (2002) (79)
- Role of ethnicity in risk for hepatocellular carcinoma in patients with chronic hepatitis C and cirrhosis. (2004) (78)
- Survival after liver transplantation in patients with hepatic iron overload (2005) (78)
- Chronic hepatitis B: preventing, detecting, and managing viral resistance. (2008) (78)
- Treatment of severe reflux esophagitis with cimetidine and metoclopramide. (1986) (77)
- Detection and surveillance of colorectal cancer. (1989) (77)
- Response to dopamine hydrochloride in the hepatorenal syndrome. (1975) (74)
- The Epidemiology of Hepatitis C Virus Infection (2003) (74)
- Significant prevalence of histologic disease in patients with chronic hepatitis B and mildly elevated serum alanine aminotransferase levels. (2008) (74)
- Liver Biopsy for Histological Assessment – The Case Against (2010) (73)
- Liver transplantation in patients with severe obesity. (1994) (70)
- Keratins as susceptibility genes for end-stage liver disease. (2005) (70)
- Histological Disease in Asian-Americans With Chronic Hepatitis B, High Hepatitis B Virus DNA, and Normal Alanine Aminotransferase Levels (2009) (69)
- Treatment strategies for chronic hepatitis C: Update since the 1997 National Institutes of Health Consensus Development Conference (1999) (66)
- Comparison of transjugular and surgical portosystemic shunts on the outcome of liver transplantation. (1994) (66)
- Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation. (2001) (65)
- High Frequency of Recurrent Viremia After Hepatitis B e Antigen Seroconversion and Consolidation Therapy (2012) (65)
- Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. (2006) (65)
- Erythropoietic Response to Anemia in Chronic Hepatitis C Patients Receiving Combination Pegylated Interferon/Ribavirin (2005) (63)
- Management of gallstones and their complications. (2000) (62)
- Current treatment strategies for chronic hepatitis B and C. (2001) (61)
- Review article: hepatitis vaccination in patients with chronic liver disease. (2004) (60)
- Dermatologic disorders associated with chronic hepatitis C: effect of interferon therapy. (2007) (57)
- Antiviral prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. (2007) (57)
- Lupus meningitis. Antibody to deoxyribonucleic acid (DNA) and DNA:anti-DNA complexes in cerebrospinal fluid. (1974) (57)
- Training the gastroenterologist of the future: the gastroenterology core curriculum. The Gastroenterology Leadership Council. (1996) (56)
- Screening for Hepatocellular Carcinoma (2002) (56)
- Review article: current antiviral therapy of chronic hepatitis B (2008) (55)
- Management of hepatocellular carcinoma. (2003) (54)
- Higher Rate of Sustained Virologic Response in Chronic Hepatitis C Genotype 6 Treated With 48 Weeks Versus 24 Weeks of Peginterferon Plus Ribavirin (2008) (54)
- Chronic hepatitis B: early viral suppression and long‐term outcomes of therapy with oral nucleos(t)ides (2009) (53)
- Immunopathogenesis of primary biliary cirrhosis. (1999) (53)
- Prolonged cholestasis due to trimethoprim sulfamethoxazole. (1992) (53)
- Chronic hepatitis C with normal aminotransferase levels. (2004) (53)
- Chronic hepatitis B and hepatitis C in Asian Americans. (2003) (50)
- Chronic hepatitis C: genotypes 4 to 9. (2005) (50)
- High rate of unemployment after liver transplantation: Analysis of the United Network for Organ Sharing database (2012) (49)
- Hepatitis B vaccination of patients with chronic liver disease. (1998) (48)
- Summary of guidelines on organ allocation and patient listing for liver transplantation. (1998) (48)
- An algorithm for the management of hepatic encephalopathy (2007) (48)
- Impact of Age Older Than 60 Years in Living Donor Liver Transplantation (2007) (48)
- Patterns of hepatitis C viremia in patients receiving hemodialysis. (1997) (47)
- Hepatitis B vaccines. (2004) (47)
- In vitro effect of bile salts on rat liver plasma membrane, lipid fluidity, and ATPase activity (1981) (47)
- Primary liver transplantation without transfusion of red blood cells. (1996) (47)
- Prophylaxis Against Chemotherapy-Induced Reactivation of Hepatitis B Virus Infection With Lamivudine (2003) (46)
- New and emerging treatment of chronic hepatitis B. (2007) (46)
- Diabetes Mellitus Increases the Risk of Mortality Following Liver Transplantation Independent of MELD Score (2010) (45)
- Thiazolides: a new class of drugs for the treatment of chronic hepatitis B and C. (2008) (45)
- Quality of life and employment after liver transplantation (2001) (45)
- Treatment of chronic viral hepatitis with nitazoxanide and second generation thiazolides. (2009) (44)
- Treatment of Chronic Hepatitis C Using a 4-week Lead-in With Nitazoxanide Before Peginterferon Plus Nitazoxanide (2009) (42)
- Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group. (1997) (41)
- Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection (2011) (41)
- Helicobacter pylori infection and blood group antigens: lack of clinical association. (1996) (39)
- Orthotopic liver transplantation for hepatocellular carcinoma. Factors affecting long-term patient survival. (1996) (39)
- Long-term follow-up after liver transplantation in patients with hepatic iron overload. (1999) (38)
- Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy. (2011) (37)
- Chronic hepatitis B: a critical appraisal of current approaches to therapy. (2006) (34)
- Pseudomembranous enterocolitis. Resurgence related to newer antibiotic therapy. (1974) (34)
- Hepatotoxicity of transplant immunosuppressive agents. (1995) (34)
- Occupational risk for hepatitis A: a literature-based analysis. (2004) (34)
- Epidemiology and treatment outcomes of patients with chronic hepatitis C and genotypes 4 to 9. (2004) (33)
- Handbook of Liver Disease (2011) (33)
- Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression. (1995) (33)
- Liver transplantation in Asian patients with chronic hepatitis B (1997) (32)
- Liver transplantation: evolving patient selection criteria. (2001) (32)
- Pancreatic insufficiency associated with ulcerative colitis and pericholangitis. (1982) (32)
- Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration (1999) (31)
- Disulfiram hypersensitivity hepatitis. (1974) (31)
- Steatosis and cirrhosis in an obese diabetic. Resolution of fatty liver by fasting. (1987) (31)
- Colonoscopy preps: what's best? (1996) (31)
- Sarcoidosis and primary biliary cirrhosis. Literature review and illustrative case. (1987) (31)
- Sedation and analgesia for endoscopy. (1995) (31)
- New approaches to supporting the failing liver. (1998) (30)
- Isolated Aspartate Aminotransferase Elevation: Think Macro-AST (2011) (30)
- Liver transplantation for treatment of giant hepatocellular adenomas. (1995) (30)
- Digestive Diseases and Sciences—Past, Present, and Future (2008) (29)
- Diagnosis and treatment of chronic hepatitis B: 2009 update. (2009) (29)
- Fulminant hepatic failure secondary to neoplastic infiltration of the liver. (2005) (28)
- T cell immunity in hepatitis B and hepatitis C virus infection: implications for autoimmunity. (2005) (28)
- Treatment of hepatic failure secondary to isoniazid hepatitis with liver transplantation (1994) (28)
- Is Oral l-Acyl-Carnitine an Effective Therapy for Hepatic Encephalopathy? Review of the Literature (2008) (28)
- Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy (2001) (28)
- Clinical outcome after percutaneous transhepatic obliteration of esophageal varices. (1983) (28)
- A novel technique for endoscopic removal of expandable biliary Wallstent. (1999) (27)
- Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B (2009) (27)
- Hepatitis A in patients with chronic liver disease – severity of illness and prevention with vaccination (2000) (27)
- Hepatitis B vaccines. (2006) (27)
- Chronic viral hepatitis: epidemiology, molecular biology, and antiviral therapy. (2011) (26)
- Resection versus transplantation for hepatocellular carcinoma (1999) (26)
- Employment after liver transplantation: a review. (2015) (26)
- IL-28B As a Predictor of Sustained Virologic Response in Patients with Chronic Hepatitis C Virus Infection. (2011) (26)
- Do we still need a liver biopsy? Are the serum fibrosis tests ready for prime time? (2006) (25)
- Liver transplantation in patients with hepatitis B virus infection: Outcome in asian versus white patients (2001) (25)
- Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group. (1997) (24)
- Hepatitis G virus: is it a hepatitis virus? (1997) (24)
- End‐stage liver disease and liver transplantation: Role of lamivudine therapy in patients with chronic hepatitis B (2000) (24)
- Endoscopic gastrointestinal manifestations of liver disease. (2001) (23)
- 68 RANDOMIZED CONTROLLED TRIAL OF NITAZOXANIDE-PEGINTERFERON-RIBAVIRIN, NITAZOXANIDE-PEGINTERFERON AND PEGINTERFERON-RIBAVIRIN IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 4 (2008) (23)
- Acute pancreatitis after gastrointestinal endoscopy. (2002) (23)
- Role of liver biopsy in the management of chronic liver disease: selective rather than routine. (2005) (23)
- Similar Treatment Response to Peginterferon and Ribavirin in Asian and Caucasian Patients With Chronic Hepatitis C (2010) (23)
- Hepatocellular carcinoma in arteriohepatic dysplasia. (1993) (22)
- Liver transplantation at the millennium. Past, present, and future. (2000) (22)
- Isolated metastasis to small bowel from anaplastic thyroid carcinoma. With a review of extra-abdominal malignancies that spread to the bowel. (1987) (22)
- Patient selection and listing policies for liver transplantation (1999) (21)
- Esophageal burn and the microwave oven. (1982) (21)
- Study of adherence comes to the treatment of chronic hepatitis B. (2011) (20)
- Are hepatitis B e antigen (HBeAg)-positive chronic hepatitis B and HBeAg-negative chronic hepatitis B distinct diseases? (2008) (19)
- Chronic hepatitis C: management of treatment failures. (2005) (19)
- Comorbidities of alcoholic liver disease that affect outcome of orthotopic liver transplantation. (1997) (19)
- Steatosis and cirrhosis in an obese diabetic (1987) (18)
- Long‐term survival of patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoinfusion (2007) (18)
- Atlas of Gastrointestinal Endoscopy (1998) (18)
- Relationship between biochemical and virological responses to interferon therapy in chronic hepatitis C infection (1998) (18)
- Acute pancreatitis associated with acute hepatitis A. (1992) (18)
- Prospective study of risk factors for hepatitis C virus acquisition by Caucasian, Hispanic, and Asian American patients (2012) (18)
- An appraisal of patients' reactions to "informed consent" for peroral endoscopy. (1977) (18)
- Severe and prolonged oral contraceptive jaundice. (1984) (18)
- Peginterferon vs. standard interferon in the treatment of chronic hepatitis C (2003) (17)
- Isolation of a rat liver plasma membrane fraction of probable canalicular origin. Preparative technique, enzymatic profile, composition, and solute transport. (1981) (17)
- Diagnosis of sclerosing cholangitis with technetium 99m-labeled iminodiacetic acid planar and single photon emission computed tomographic scintigraphy. (1987) (17)
- Asymptomatic elevation of aminotransferase levels and fatty liver secondary to heterozygous hypobetalipoproteinemia (1998) (17)
- Risk of tuberculosis in tuberculin skin test-positive liver transplant patients. (1999) (16)
- Management of variceal hemorrhage in the potential liver transplant candidate. (1989) (16)
- Clinical outcomes of liver transplantation for HBV‐related hepatocellular carcinoma: data from the NIH HBV OLT study (2011) (16)
- Diagnosis and treatment of primary biliary cirrhosis. (2000) (16)
- Future Treatment of Chronic Hepatitis C (2007) (15)
- Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate (1982) (15)
- Assessment of the alcoholic patient for liver transplantation: comorbidity, outcome, and recidivism. (1996) (15)
- Liver transplantation for uncontrollable variceal bleeding. (1994) (15)
- Pulmonary varices presenting as a solitary lung mass in a patient with end-stage liver disease. (1994) (15)
- High Rate of Complete Viral Suppression With Combination Therapy in Patients With Chronic Hepatitis B and Prior Treatment Failure (2011) (14)
- Quality of life, employment, and alcohol consumption after liver transplantation (2001) (14)
- Pathogenesis of primary biliary cirrhosis. (2003) (14)
- Chapter Thirty-Six – Alcoholic and nonalcoholic fatty liver disease (2006) (13)
- Management of the pregnant hepatitis B patient (2008) (13)
- Scintigraphic Criteria for the Diagnosis of Obstructive Hepatobiliary Diseases with Tc-99m IDA (1988) (13)
- Serum gamma-glutamyl transpeptidase activity in patients receiving chronic phenytoin therapy (1986) (13)
- Screening flexible sigmoidoscopy by primary care physicians. Effectiveness and costs in patients negative for fecal occult blood. (1986) (13)
- Primary sclerosing cholangitis in ulcerative colitis. (1985) (13)
- Diagnosis and treatment of chronic hepatitis B. (2004) (13)
- Sclerotherapy versus banding in the treatment of variceal bleeding. (1997) (13)
- Management of chronic hepatitis C treatment failures: role of consensus interferon (2009) (13)
- Hematologic side effects of PEG interferon and ribavirin. Management with growth factors. (2005) (13)
- Recurrent obstructive jaundice caused by fibrolamellar hepatocellular carcinoma (1984) (12)
- Living donor liver transplantation in a patient with hepatic epithelioid hemangioendothelioma. (2003) (12)
- Aortoduodenal fistula: complication of renal artery bypass graft. (1974) (12)
- 1049 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE PLUS PEGINTERFERON AND RIBAVIRIN IN HCV GENOTYPE 1 PATIENTS: INTERIM ANALYSIS SHOWS INCREASE IN EVR (2009) (12)
- Nucleoside analogues and other antivirals for treatment of hepatitis B in the peritransplant period. (2003) (12)
- Portal hypertensive hemorrhage from a left gastroepiploic vein caput medusa in an adhesed umbilical hernia. (2005) (11)
- Primary biliary cirrhosis: Tc-99m IDA planar and SPECT scanning. (1988) (11)
- Hepatitis C virus and liver transplantation. (2001) (11)
- Antibiotics in the management of hepatic encephalopathy: an evidence-based review. (2005) (11)
- Liver transplantation for alcoholic liver disease: selection and outcome. (1997) (11)
- Overview of interferon therapy for chronic hepatitis C. (1999) (11)
- Controversies in patient selection for liver transplantation. (1993) (11)
- Therapy for collagenous colitis. (1987) (10)
- EVALUATION OF MILDLY ABNORMAL LIVER TESTS IN ASYMPTOMATIC PATIENTS (1990) (10)
- Entecavir for the long-term treatment of chronic hepatitis B (2009) (10)
- Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy. (2001) (10)
- Outcomes and effectiveness research: the 1992 investigator conference of the American Society for Gastrointestinal Endoscopy. (1993) (10)
- Milestones in liver transplantation for alcoholic liver disease. (1997) (10)
- Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection (2011) (10)
- Hematologic manifestations of gastrointestinal disease. (1987) (10)
- Acute appendicitis secondary to metastatic cholangiocarcinoma. (1993) (9)
- Diagnosis and treatment of chronic hepatitis B: an update. (2007) (9)
- 2001 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NITAZOXANIDE PLUS PEGINTERFERON AND RIBAVIRIN IN HCV GENOTYPE 1 NAIVE PATIENTS: WEEK 12 SUSTAINED VIROLOGIC RESPONSE RATE (2010) (9)
- 832 EVALUATION OF A 4 WEEK LEAD-IN PHASE WITH NITAZOXANIDE PRIOR TO NITAZOXANIDE+PEGINTERFERON IN TREATING CHRONIC HEPATITIS C (2008) (9)
- Prevalence of hepatitis B virus genotype B in Vietnamese patients with chronic hepatitis B (2009) (9)
- Hepatitis B: modern end points of treatment and the specter of viral resistance. (2011) (9)
- Management of chronic hepatitis B in challenging patient populations (2006) (9)
- 1188 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF NITAZOXANIDE WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN NONRESPONDERS (NR) WITH CHRONIC HEPATITIS C GENOTYPE 1: FINAL REPORT (2010) (9)
- Diabetes and the hepatobiliary system. (1998) (9)
- S2075 Prevalence of HBV DNA Polymerase (B-DNA Pol) Mutations in 345 Patients with Treatment-NaïVe Chronic Hepatitis B (CHB) (2008) (9)
- Colonic lymphoma in the transplant patient (2005) (8)
- Cost-effective evaluation of acute viral hepatitis. (2000) (8)
- Risk assessment for hepatocellular carcinoma in chronic hepatitis B: scores and surveillance (2012) (8)
- Chronic hepatitis B with advanced fibrosis or cirrhosis: impact of antiviral therapy. (2007) (8)
- Liver transplantation in patients with hepatic iron overload: Favorable or unfavorable outcome? (2000) (8)
- The immunopathology of primary biliary cirrhosis: thoughts for the millennium. (2000) (8)
- 1059 PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED STUDY OF NITAZOXANIDE WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN NONRESPONDERS (NR) WITH CHRONIC HCV GENOTYPE 1: WEEK 28 INTERIM ANALYSIS (2009) (8)
- Hepatitis B: explosion of new knowledge. (2007) (8)
- Management of chronic liver failure until liver transplantation. (2008) (8)
- Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C. Consensus Interferon Study Group. (1999) (7)
- Initial two-year results of the Oregon Liver Transplantation Program. (1991) (7)
- Ruptured abdominal aortic aneurysm causing obstructive jaundice (2005) (7)
- Hepatitis G virus: clinical relevance and responsiveness to interferon. (1997) (7)
- Adenomatous polyp arising in Barrett's esophagus. (1986) (7)
- Retreatment of chronic hepatitis C virus infection. (2004) (6)
- Utility of hepatitis C virus serotypes in predicting response to treatment of chronic hepatitis C. Consensus Interferon Study Group. (1999) (6)
- Diabetic gastroparesis. (1995) (6)
- SIGNIFICANCE OF MILDLY ELEVATED LIVER TESTS ON SCREENING BIOCHEMISTRY PROFILES (1990) (6)
- Technical Monitoring During Radiologic Interventions — What Can Be Done and What Must Be Done (1993) (6)
- Advances in liver disease. Highlights from the 51st Annual Meeting of the American Association for the Study of Liver Diseases, October 27-31, 2000, Dallas, TX. (2001) (6)
- Advances in gastrointestinal pharmacotherapy. (2005) (6)
- Aortic valve endocarditis after orthotopic liver transplantation. (1994) (6)
- Primary biliary cirrhosis: lessons learned from an organ-specific disease. (2001) (6)
- Peginterferons in hepatitis C virus: virological, pharmacokinetic, and clinical implications. Introduction. (2003) (6)
- Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis. (2001) (5)
- Recent developments in the treatment of chronic hepatitis B virus infection (1995) (5)
- Advancing the Clinical Treatment of Hepatitis B Virus (2005) (5)
- Long‐term management of the liver transplant patient (2001) (5)
- A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide Plus Peginterferon and Ribavirin in Naïve Patients With Chronic Hepatitis C Genotype 1 Infection: Final Report (2010) (5)
- Hypoglycemic coma in a pregnant woman in association with hepatitis B virus carrier state and hepatocellular carcinoma. (2004) (5)
- NAFLD and NASH: Important diseases before and after liver transplantation (2001) (5)
- Long-Term Effects of Antiviral Therapy in Patients with Chronic Hepatitis C (2010) (5)
- Ileal volvulus following colonoscopy. (1985) (5)
- 831 RANDOMIZED DOUBLE BLIND PLACEBO-CONTROLLED TRIAL OF NITAZOXANIDE IN THE TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 4 (2008) (5)
- Clinical approach to viral hepatitis in homosexual men. (1986) (5)
- A review of the use of telbivudine in the treatment of chronic hepatitis B (2009) (4)
- Patient selection criteria for liver transplantation. (2003) (4)
- Risk score for development of HCC: ready for use in practice? (2011) (4)
- Hepatitis B virus reactivation with chemotherapy: diagnosis and prevention with antiviral prophylaxis. (2004) (4)
- Prednisone withdrawal advocates: Beware of recurrent autoimmune hepatitis (1999) (4)
- IS LAMIVUDINE BENEFICIAL IN HBSAG+ PATIENTS AWAITING LIVER TRANSPLANTATION? EXPERIENCE IN 182 NORTH AMERICAN PATIENTS. (1999) (4)
- Relationship between physical and functional properties of canaliculi-enriched liver plasma membranes (LPM) and canalicular bile flow (1978) (4)
- Alanine aminotransferase levels are not significantly elevated in patients with HIV/HBV co-infection and lamivudine resistance (2008) (4)
- 1014 Evaluation and outcomes of combination therapy with interferon or peginterferon plus ribavirin in 67 Southeast Asian patients with hepatitis C genotypes 6, 7, 8, and 9 (2003) (4)
- IL-28 B As a Predictor of Sustained Virologic Response in Patients with Chronic Hepatitis C Virus Infection (2013) (3)
- Endoscopic Procedural Safety (1991) (3)
- Taurocholate: A rapid regulator of canalicular hembrane NaK-ATPase activity (1978) (3)
- Psychological assessment of quality of life following liver transplantation (1994) (3)
- Handbook of Liver Disease, 3rd Edition Expert Consult - Online and Print (2011) (3)
- Chapter 2 – Acute liver failure (2004) (3)
- Erythropoietic response to anemia is decreased in patients infected with hepatitis C virus (HCV) receiving combination ribavirin and pegylated interferon (RBV/PEG-IFN) therapy (2003) (3)
- The successful use of telemedicine in acute variceal hemorrhage. (1999) (3)
- Antibiotic Prophylaxis: Who, When, and How (1993) (3)
- Differential diagnosis of gallstone-induced complications. (2000) (3)
- Treatment of Chronic Hepatitis B (CHB) with Nitazoxanide (Ntz) Alone or Ntz Plus Adefovir (ADV) for Two Years with Loss of Hepatitis B E Antigen (HBeAg) and Hepatitis B Surface Antigen (HbsAg): Report of Two Cases (2008) (3)
- Prevalence of HBV precore and core promotor variants in the United States — results of a nation-wide study (2002) (3)
- HEPATOLOGY: A CENTURY OF PROGRESS LIVER TRANSPLANTATION AT THE MILLENNIUM Past, Present and Future (2000) (3)
- Best of the AASLD. Highlights from the 52nd Annual Meeting of the American Association for the Study of Liver Diseases. November 9-13, 2001, Dallas, TX. (2002) (3)
- Chapter 49 – Pretransplant Evaluation and Care (2006) (3)
- Impact of organ shortage on liver transplantation (2001) (3)
- Trichobezoar associated with gastric polyposis. (1988) (3)
- Liver transplantation at California Pacific Medical Center, San Francisco, California. (1994) (3)
- Comparative effects of blood, colloid, and Ringer's lactate terminal allograft rinse on the results of orthotopic liver transplantation. (1993) (3)
- Association of Hepatocellular Carcinoma (HCC) With Hepatitis B Virus (HBV) Versus Hepatitis C Virus (HCV) Infection Among Different Asian Subgroups (2011) (2)
- Annals of Clinical Microbiology and Anti microbials (2005) (2)
- The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults. (2007) (2)
- Chronic hepatitis B and C: update on therapy (2009) (2)
- Liver transplantation in elderly patients (1993) (2)
- Fibrocystic Diseases of the Liver. Karen F. Murray and Anne M. Larson, editors. 640 pp. $239.00. Totowa, New Jersey, Humana Press. ISBN: 9-7816-0327-5231. Web address for ordering:www.springer.com (2011) (2)
- 157 – Hepatic Failure and Liver Transplantation (2012) (2)
- Dual effects of hepatitis B (HBV) infection and hepatitis B immunoglobulin (HBIg) in reducing the incidence of acute rejection post-transplantation (1998) (2)
- Current Issues in the Management of Hepatitis A and B (2007) (2)
- Chronic hepatitis C in the human immunodeficiency virus-infected patient: management strategies. (2006) (2)
- Role of emerging technology in the era of cost containment. (1997) (2)
- Progressive asymptomatic occlusion of a TIPS in a patient with Budd-Chiari syndrome. (2006) (2)
- Diagnosis of primary sclerosing cholangitis in a blood donor with elevated serum alanine aminotransferase. (1989) (2)
- Update on liver transplantation. (2004) (2)
- Gastroenterology in the 21st century--strength in unity: 1996 presidential address. (1996) (2)
- Risk factors for hepatocellular carcinoma in patients with chronic liver disease: a case–control study (2012) (2)
- Liver transplantation--challenges for the future. (1991) (1)
- S2071 Vietnamese Patients with Chronic Hepatitis B (CHB) Exhibit Different Viral Genotype Distributions Than Chinese Patients (2008) (1)
- Presidential address during the AGA Plenary Session. (2005) (1)
- Liver transplantation at Stanford University Medical Center. (1998) (1)
- 62 Measuring Quality of Care in Patients with Cirrhosis: Development of An Explicit Quality Indicator Set (2009) (1)
- Primary biliary cirrhosis: lessons learned from an organic-specific disease (2001) (1)
- 376 SYSTEMATIC REVIEW AND META-ANALYSIS: PREVALENCE OF SIGNIFICANT HISTOLOGIC DISEASE IN CHRONIC HEPATITIS B INFECTION, HIGH HBVDNA, AND PERSISTENTLY NORMAL SERUM ALT (PNALT) (2011) (1)
- Chapter 5 – Laboratory Tests (2006) (1)
- S2084 Significant Prevalence of Histologic Disease in Chronic Hepatitis B Patients with Mildly Elevated Serum Alanine Aminotrasferase Levels (2008) (1)
- Best of DDW 2006. (2006) (1)
- UpToDate Liver Practice Guidelines (2007) (1)
- MELD Score: The Implementation of Evidence-based Selection Criteria for Allocation of Donor Livers A SPECIAL ARTICLE (2003) (1)
- 1214 DOSE-RELATED INCREASE IN VIROLOGIC RESPONSES USING CONTROLLED RELEASE NITAZOXANIDE PLUS PEGINTERFERON ALFA-2A AND RIBAVIRIN FOR TREATMENT OF CHRONIC HEPATITIS C GENOTYPE 4: FINAL REPORT (2011) (1)
- Hepatitis B Virus (HBV) Reverse Transcriptase Mutation Prevalence Was Low in Treatment-NaïVE Patients With Chronic Hepatitis B (CHB) Using Inno-Lipa HBV DR3 in a Prospective Multicenter Study (2011) (1)
- Serum des-gamma-carboxyprothrombin for the screening of hepatocellular carcinoma in cirrhotic patients: A meta-analysis (2000) (1)
- Update on chronic hepatitis C. (2003) (1)
- Hepatitis C Virus Infection (2009) (1)
- [Acute liver failure]. (2005) (1)
- Predictive value of the timing of ALT and HCV RNA responses in defining patients who will have a virologic-sustained response after six months of interferon therapy (1998) (1)
- Chronic Viral Hepatitis and Liver Transplantation (2002) (1)
- S2077 Almost Half of the Chronic Hepatitis B (CHB) Patients with Positive HBeAg Have Confirmed Precore and/or Basal Core Promoter (PREC/BCP) Mutations (2008) (1)
- PULSE OXIMETRY : TRAINING AND KNOWLEDGE. COMMENTARY (1998) (1)
- Liver disease: hepatitis B. Treatment of chronic hepatitis B With entecavir. (2006) (1)
- TREATMENT OF CHRONIC HEPATITIS B WITH ENTECAVIR: HIGH POTENCY AND ABSENT VIRAL RESISTANCE WITH 1 YEAR OF THERAPY (2006) (1)
- Too many liver biopsies in patients with chronic hepatitis C (2001) (1)
- Current perspectives: liver transplantation in the elderly (2005) (1)
- Treatment of the hepatorenal syndrome (HRS) with dopamine (1974) (0)
- hepatitis C virus infection Impaired dendritic cell maturation in patients with chronic, but not resolved, (2013) (0)
- Management of hepatitis B in patients with HBeAg-negative disease (2007) (0)
- 636 High Rate of Complete Viral Suppression With Combination Therapy With Tenofovir Using Entecavir or Lamivudine/Emtricitabine in Patients With Chronic Hepatitis B and Prior Monotherapy Failure (2010) (0)
- Reply of the authors: Liver Plasma Membrane Fluidity: An Important Factor in Bile Flow (1980) (0)
- Emerging Hepatitis B Therapeutics (2005) (0)
- Racial differences in risk for liver cancer in patients with hepatitis C cirrhosis: A multicenter case-control study (2003) (0)
- M1892 Hepatitis B-E Antigen Positive (HBeAg+) Chronic Hepatitis B (CHB) Patients With Precore (PC) and Basic Core Promoter (BCP) Mutations (2010) (0)
- Current Treatment of Chronic Hepatitis B (2009) (0)
- Hepatitis B virus genotype: A missing link in transmission risk and disease progression? (2008) (0)
- Liver transplantation and surgery (1992) (0)
- M1786 Response to Peginterferon (PEG IFN) and Ribavirin (RBV) in Asian Americans and Non-Asian Americans with Chronic Hepatitis C (CHC) in a Real-Life Community Setting: A Multi-Center Study (2009) (0)
- Chapter 31 – Liver transplantation (2004) (0)
- Incidence and Predictors of Hepatitis B E Antigen (HBeAg) Seroconversion in Chronic Hepatitis B (CHB) Patients Treated With Anti-HBV Therapy in Routine Clinical Practice (2011) (0)
- M1886 Transcatheter Arterial Chemoinfusion (TACI) Is Effective As a Bridge Towards Orthotopic Liver Transplantation and Downstaging to Maintain or Achieve Milan Criteria in Patients with Unresectable Hepatocellular Carcinoma (HCC) (2008) (0)
- Hepatitis B and D Protocols (vol I & II) (2005) (0)
- Approach to patients with HBV and HCV coinfection (2008) (0)
- Comprar Handbook of Liver Disease, 3rd Edition Expert Consult - Online and Print | Emmet B. Keeffe | 9781437717259 | Saunders (2011) (0)
- Differential response to treatment with consensus interferon (CIFN) and IFN alpha-2b in chronic HCV patients infected with different (1996) (0)
- Outcomes of liver transplantation in patients with obesity and patients with inflammatory bowel disease. (2002) (0)
- In Memoriam: Emmet B. Keeffe, MD (2011) (0)
- TREATMENT OUTCOMES OF TRANSCATHETER ARTERIAL CHEMOINFUSION (TACI) IN PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA (HCC): 253 (2004) (0)
- Special Issue: Pegylated interferon and ribavirin treatment for hepatitis C virus infection. (2010) (0)
- Efficacy and Tolerability of Entecavir (ETV) after Liver Transplantation (LT) for Chronic Hepatitis B (CHB): 274 (2011) (0)
- Diagnosis of sclerosing cholangitis (SC) by Tc-99m-disida SPECT imaging (1985) (0)
- Incidence of Hepatitis B E Antigen (HBeAg) Seroconversion and Suboptimal Response in Chronic Hepatitis B (CHB) Patients Treated With Entecavir 0.5 mg Daily in Routine Clinical Practice (2011) (0)
- Adefovir (ADV) Partial Response in Patients with Chronic Hepatitis B (CHB): Switch Versus Add-On Therapy: 275 (2011) (0)
- High Rate of Recurrent Hepatitis B Viremia Following Treatment-Induced Hepatitis B E Antigen (HBeAg) Seroconversion (2011) (0)
- HBV Precore C1858T Mutation Does Not Share Similar Clinical or Virologic Characteristics With Other Precore Mutants (2011) (0)
- HEPATITIS C IS A MAJOR ETIOLOGY FOR HCC IN VIETNAMESE AMERICANS: 260 (2004) (0)
- nitazoxanide combined with peginterferon and ribavirin for the treatment of chronic hepatitis C and very preliminary experiences with nitazoxanide for the treatment of chronic hepatitis B. ANTIVIRAL MECHANISM OF ACTION (2009) (0)
- Sustained Virological Response to Interferon-Based Antiviral Therapy by Viral Genotype in Recurrent Hepatitis C Patients Following Liver Transplantation: 342 (2007) (0)
- Book Reviews (1929) (0)
- Liver Immunology (2003) (0)
- Determinants of safe endoscopy. (1994) (0)
- Current and Evolving Guidelines for the Treatment of Chronic Hepatitis C (2010) (0)
- Access to Care and Optimal Treatment of Chronic Hepatitis B in Asian Americans: An Evolving Agenda (2011) (0)
- Systematic Review and Meta-Analysis: Prevalence of Significant Histologic Disease in Chronic Hepatitis B Infection, High HBV DNA, and Persistently Normal Serum ALT (PNALT) (2011) (0)
- Conferences and Reviews Controversies in Patient Selection for Liver Transplantation (0)
- Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion. (1991) (0)
- T1967 Asian Ethnicity is a Significant Predictor for Viral Dominance by HBV in HBV/HCV Co-Infected Patients: A Multicenter, Matched Case-Control Study (2010) (0)
- A new and highly prevalent keratin mutation in patients with liver disease (2003) (0)
- The evolving treatment of chronic hepatitis B : A clinical update (2007) (0)
- Endoscopic management of gastrointestinal hemorrhage (1988) (0)
- M1893 Hepatitis B Virus Reverse Transcriptase Mutations Were Not Detected in Treatment-NaïVE Patients With Chronic Hepatitis B Using Inno Lipa HBV DR3: A Prospective Multicenter Study (2010) (0)
- Vaccination against hepatitis b in patients with chronic liver disease (2006) (0)
- Medical Care of the Liver Transplant Patient (1998) (0)
- Validation of an improved assay for ATPase activity in canaliculi-enriched liver plasma membranes (LPM) (1978) (0)
- Best of DDW 2004: Highlights from the 2004 Digestive Disease Week (2004) (0)
- Conferences and Reviews Hepatitis GVirus: IsitaHepatitis Virus? (1997) (0)
- LEAD POISONING AS AN ETIOLOGY OF ABDOMINAL PAIN AND INTESTINAL PSEUDO-OBSTRUCTION IN ADULTS: 324 (2004) (0)
- Life-Threatening Hepatic Failure Associated with Entecavir Resistance Mutations I269I/T and T184L Two Years after Discontinuation of Lamivudine: 560 (2007) (0)
- WHAT THE GASTROENTEROLOGISTS KNOW THAT OTHERS MAY NOT (2002) (0)
- 301 INFRADURE: SUSTAINED INTERFERON-ALPHA (IFNα) PRODUCTION AND DELIVERY BY DERMAL MICROORGAN BIOPUMPS (2010) (0)
- Prophylactic Tips for Large Gastric Varices: A Pilot Study with Four-Year Prospective Experience (2005) (0)
- Hepatitis C: Clinic-Basic Interface (2005) (0)
- Progress in liver diseases, Volume XI. Edited by J.L. Boyer and R.K. Ockner, 306 pp. Philadelphia: W.B. Saunders Co., 1993, $79 (1994) (0)
- Getting to the cause of abnormal liver function test results (2007) (0)
- Progress in liver diseases, volume XI Edited by J.L. Boyer and R.K. Ockner, 306 pp. Philadelphia: W.B. Saunders Co., 1993, $dollar;79 (1994) (0)
- [Treatment of chronic hepatitis C with protease inhibitors: dawn of a new era]. (2010) (0)
- A critical appraisal of current approaches to treatment of chronic hepatitis B (CHB)based on a review by an international panel of investigators and a survey of AASLD membership (2005) (0)
- LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA AND THE ROLE OF PREOPERATIVE CHEMOEMBOLIZATION.: Abstract# 394 Poster Board #‐Session: P34‐II (2000) (0)
- HBV viral kinetics and clinical management: key issues and current perspectives. Proceedings of a scientific and clinical expert panel meeting. Chicago, Illinois, USA, October 18, 2003. (2004) (0)
- S2076 Age≥35 Years Is a Predictor of Significant Histology in Chronic Hepatitis B (CHB) Patients with Normal ALT Even with Stricter Cut-Offs (≤30 for Men and ≤19 for Women) (2008) (0)
- Treatment of chronic hepatitis B with peginterferon. (2005) (0)
- A Salute to the AGA Legacy Society (2016) (0)
- Guide to Liver Transplantation, T.L. Fabry, F.M. Klion (Eds.). Igaku-Shoin, New York (1992), 334, $98.50 (1993) (0)
- Variation in antibody reactivity to the hepatitis C virus by comparative immunoscreening and enzyme immunoassay. (1993) (0)
- SCLEROTHERAPY AND CORTICOSTEROIDS : A WORD OF CAUTION. REPLY (1990) (0)
- 288 INFRADURE: SUSTAINED DELIVERY OF INTERFERON-ALPHA (IFNα) IN SCID MICE BY IMPLANTED IFNA SECRETING DERMAL BIOPUMPS (2010) (0)
- S1280 Ethnicity, Alcohol Consumption, and Cigarette use as Predictors for Hepatocellular Carcinoma: A Prospective Study (2010) (0)
- Training in endoscopic procedures. (1997) (0)
- M2068 Correlation Between Serum Alpha-Fetoprotein and Alanine Aminotransferase Levels in Acute and Chronic Liver Disease (2009) (0)
- S1900 Both Hepatitis C and B Virus Were Major Underlying Etiologies for Hepatocellular Carcinoma (HCC) in Vietnamese Americans While the Vast Majority of HCC Cases in Chinese Americans Were Associated With Hepatitis B Virus (2010) (0)
- Diagnostic features of primary biliary cirrhosis compared with sclerosing cholangitis by technetium 99m diisopropyliminodiacetic acid scintigraphy (1986) (0)
- Treatment of chronic hepatitis C in patients coinfected with human immunodeficiency virus and hepatitis C virus. (2005) (0)
- Hepatitis C Virus (2005) (0)
- Liver transplantation (1996) (0)
- Abstract No. 190: Chemoembolization Downstaging of Hepatocellular Carcinoma for Liver Transplantation (2009) (0)
- Upodate on chronic hepatitis C (2003) (0)
- Don't forget vaccination against hepatitis A and B in patients with chronic hepatitis C.* (2001) (0)
- Ethnic Differences in Etiology, Staging and Treatment Eligibility of Patients With Hepatocellular Carcinoma (HCC) (2011) (0)
- Hepatitis B Vaccination: Current and Evolving Recommendations (2011) (0)
- Predictors of Long Term Outcome Following Transjugular Intrahepatic Portosystemic Shunt (TIPS): 420 (2008) (0)
- DIAGNOSIS OF PRIMARY BILIARY CIRRHOSIS (PBC), SCLEROSING CHOLANGITIS (SC), AND ISOLATED COMMON BILE DUCT OBSTRUCTION (ICBDO) BY Tc‐99m‐IDA SCINTIGRAPHY: P11 (1986) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Emmet B. Keeffe?
Emmet B. Keeffe is affiliated with the following schools: